Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Confronto Tra Radiomica e i Criteri Convenzionali di Risposta Nella Previsione Della Progressione Del Tumore Desmoide Dopo Crioablazione

NCT06224283 is registered in ClinicalTrials.gov with Istituto Ortopedico Rizzoli as lead sponsor.

NCT NCT06224283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06224283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Confronto Tra Radiomica e i Criteri Convenzionali di Risposta Nella Previsione Della Progressione Del Tumore Desmoide Dopo Crioablazione
Lead sponsor
Istituto Ortopedico Rizzoli
Phase
Observational
Overall status
Recruiting
Start date
February 20, 2024
Completion date
October 31, 2026
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid